168 related articles for article (PubMed ID: 36965889)
1. Comparison of the treatment efficacies of HIFU, HIFU combined with GnRH-a, and HIFU combined with GnRH-a and LNG-IUS for adenomyosis: A systematic review and meta-analysis.
Otgontuya A; Jeng CJ; Wu TN; Chuang LT; Shen J
Taiwan J Obstet Gynecol; 2023 Mar; 62(2):226-238. PubMed ID: 36965889
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of high-intensity focused ultrasound combined with LNG-IUS for adenomyosis: a systematic review and meta-analysis.
Zhao TT; Pang LL; Yang LL; Li RN; Fan LX; Wen Y
Arch Gynecol Obstet; 2023 Aug; 308(2):351-362. PubMed ID: 35947146
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of HIFU combined with GnRH-a and LNG-IUS for adenomyosis patients who failed to respond to drug therapies: two-year follow-up results.
Peng Y; Dai Y; Yu G; Yang X; Wen C; Jin P
Int J Hyperthermia; 2021; 38(1):1271-1275. PubMed ID: 34423729
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of high-intensity focused ultrasound ablation combined with mifepristone and levonorgestrel-releasing intrauterine system to treat symptomatic adenomyosis.
Zhu H; Ma Q; Dong G; Yang L; Li Y; Song S; Mu Y
Int J Hyperthermia; 2023; 40(1):2161641. PubMed ID: 36586419
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of high intensity focused ultrasound ablation combined with GnRH-a and LNG-IUS for the treatment of adenomyosis].
Ye MZ; Deng XL; Zhu XG; Xue M
Zhonghua Fu Chan Ke Za Zhi; 2016 Sep; 51(9):643-649. PubMed ID: 27671043
[No Abstract] [Full Text] [Related]
6. Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis.
Yang X; Zhang X; Lin B; Feng X; Aili A
Int J Hyperthermia; 2019; 36(1):486-492. PubMed ID: 30994010
[TBL] [Abstract][Full Text] [Related]
7. High-Intensity Focused Ultrasound Combined With Gonadotropin-Releasing Hormone Agonist or Levonorgestrel-Releasing Intrauterine System in Treating Dysmenorrhea of Severe Adenomyosis.
Xu Y; Zhou Z; Wang H; Shao L; Liu G
J Comput Assist Tomogr; 2021 Mar-Apr 01; 45(2):224-231. PubMed ID: 33661158
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy and safety of levonorgestrel releasing intrauterine system in the treatment of adenomyosis: evidence mapping.
Shi J; Gu Z; Wu Y; Li X; Zhang J; Zhang C; Yan H; Dai Y; Leng J
Arch Gynecol Obstet; 2024 Jul; 310(1):55-67. PubMed ID: 38836931
[TBL] [Abstract][Full Text] [Related]
9. High-intensity focused ultrasound (HIFU) combined with gonadotropin-releasing hormone analogs (GnRHa) and levonorgestrel-releasing intrauterine system (LNG-IUS) for adenomyosis: a case series with long-term follow up.
Haiyan S; Lin W; Shuhua H; Wang W
Int J Hyperthermia; 2019; 36(1):1179-1185. PubMed ID: 31793356
[No Abstract] [Full Text] [Related]
10. High intensity focused ultrasound treatment of adenomyosis: a comparative study.
Guo Q; Xu F; Ding Z; Li P; Wang X; Gao B
Int J Hyperthermia; 2018; 35(1):505-509. PubMed ID: 30306813
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of High-Intensity Focused Ultrasound Combined With GnRH-a for Adenomyosis: A Systematic Review and Meta-Analysis.
Pang LL; Mei J; Fan LX; Zhao TT; Li RN; Wen Y
Front Public Health; 2021; 9():688264. PubMed ID: 34485218
[No Abstract] [Full Text] [Related]
12. Comparison of combined transcervical resection of the endometrium and levonorgestrel-containing intrauterine system treatment versus levonorgestrel-containing intrauterine system treatment alone in women with adenomyosis: a prospective clinical trial.
Zheng J; Xia E; Li TC; Sun X
J Reprod Med; 2013; 58(7-8):285-90. PubMed ID: 23947077
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of medical treatment for adenomyosis after adenomyomectomy.
Li Q; Yuan M; Li N; Zhen Q; Chen C; Wang G
J Obstet Gynaecol Res; 2020 Oct; 46(10):2092-2099. PubMed ID: 32725682
[TBL] [Abstract][Full Text] [Related]
14. Levonorgestrel-Releasing Intrauterine System Improves Menorrhagia-Related Quality of Life in Patients with Symptomatic Adenomyosis.
Ishizawa C; Hirota Y; Iida R; Kaku T; Hirata T; Fukui Y; Omura E; Akaeda S; Hiraoka T; Matsuo M; Osuga Y
Reprod Sci; 2023 Mar; 30(3):966-973. PubMed ID: 36071343
[TBL] [Abstract][Full Text] [Related]
15. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery.
Abou-Setta AM; Al-Inany HG; Farquhar CM
Cochrane Database Syst Rev; 2006 Oct; (4):CD005072. PubMed ID: 17054236
[TBL] [Abstract][Full Text] [Related]
17. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding.
Lethaby AE; Cooke I; Rees M
Cochrane Database Syst Rev; 2005 Oct; (4):CD002126. PubMed ID: 16235297
[TBL] [Abstract][Full Text] [Related]
18. Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study.
Guo Y; Duan H; Cheng J; Zhang Y
BJOG; 2017 Aug; 124 Suppl 3():7-11. PubMed ID: 28856862
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the levonorgestrel-releasing intrauterine system in women with endometriosis.
Lan S; Ling L; Jianhong Z; Xijing J; Lihui W
J Int Med Res; 2013 Jun; 41(3):548-58. PubMed ID: 23660087
[TBL] [Abstract][Full Text] [Related]
20. Fertility-preserving treatment in patients with early-stage endometrial cancer: A protocol for systematic review and meta-analysis.
Zhao XL; Du ZQ; Zhang X; Yao Z; Liang YQ; Zhao SF
Medicine (Baltimore); 2021 Dec; 100(48):e27961. PubMed ID: 35049199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
